Viscosupplementation Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative and qualitative market trends within Patient Monitoring therapeutic area.
Viscosupplementation is the process by which the synovial fluid at the joints is replaced by an Hyaluronate preparation which has viscous properties similar to the natural synovial fluid. Viscosupplementation is used for the treatment of osteoarthritis of knee and other joints. Other joints include hip, shoulder, ankle, elbow, wrist, hand and foot. Viscosupplementation consists of a treatment cycle of Hyaluronic acid injections which come in variable volumes.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insights offer context for quantitative data.
Companies covered: Sanofi, Seikagaku Corp, Bioventus Inc, Anika Therapeutics Inc, P&R SpA, Ferring Holding SA, Zimmer Biomet Holdings Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
Viscosupplementation is the process by which the synovial fluid at the joints is replaced by an Hyaluronate preparation which has viscous properties similar to the natural synovial fluid. Viscosupplementation is used for the treatment of osteoarthritis of knee and other joints. Other joints include hip, shoulder, ankle, elbow, wrist, hand and foot. Viscosupplementation consists of a treatment cycle of Hyaluronic acid injections which come in variable volumes.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insights offer context for quantitative data.
Key Inclusions of the market model are :
Currently marketed Viscosupplementation and evolving competitive landscape :
- Insightful review of the key industry trends.
- Annualized total Viscosupplementation market revenue by segment and market outlooks from 2015-2033.
- Granular data on total procedures, units, average selling prices and market values by segment.
Global, Regional and Country level market specific insights :
- Qualitative market specific information is available with global trends further broken down into regional trends. In addition, The analyst analysts provide unique country specific insights on the market.
- SWOT analysis for Viscosupplementation market.
- Competitive dynamics insights and trends provided Viscosupplementation market.
- Country specific overview of the healthcare system.
- Country specific reimbursement policies.
- Country specific medtech regulatory landscape.
Companies covered: Sanofi, Seikagaku Corp, Bioventus Inc, Anika Therapeutics Inc, P&R SpA, Ferring Holding SA, Zimmer Biomet Holdings Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
Scope
This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for :- CMO executives who must have deep understanding of the Viscosupplementation marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.
Reasons to Buy
The model will enable you to :
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
- Develop business strategies by understanding the trends shaping and driving Viscosupplementation market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Viscosupplementation market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific Viscosupplementation market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Sanofi
- Seikagaku Corp
- Bioventus Inc
- Anika Therapeutics Inc
- P&R SpA
- Ferring Holding SA
- Zimmer Biomet Holdings Inc